The effect of recombinant human bone morphogenetic protein-2 in ingle-level posterior lumbar interbody arthrodesis

Journal of Bone and Joint Surgery

Volumn 95, Issue 10, 2013, Pages 873-880

  Michielsen, J ^a   Sys, J ^b   Rigaux, A ^a   Bertrand, C ^c  

^a AZ Monica   (Belgium)

^b Department of Orthopaedics and Traumatology   (Belgium)

^c Department of Orthopaedics and Traumatology Stichting Orthopedie   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN SPONGE; POLYETHERETHERKETONE; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; UNCLASSIFIED DRUG; WYETH; BIOMATERIAL; BONE MORPHOGENETIC PROTEIN 2; KETONE; MACROGOL DERIVATIVE; RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN-2; RECOMBINANT PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ARTHRODESIS; ARTICLE; BODY MASS; BONE DENSITY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CYST; FRACTURE HEALING; HEALING; HUMAN; LUMBAR SPINE; MAJOR CLINICAL STUDY; NERVE ENDING; ORTHOPEDIC IMPLANT; OSSIFICATION; OSTEOLYSIS; OSWESTRY DISABILITY INDEX; PAIN; PRIORITY JOURNAL; RADICULOPATHY; RANDOMIZED CONTROLLED TRIAL; SHORT FORM 36; SINGLE LEVEL POSTERIOR LUMBAR INTERBODY ARTHRODESIS; TRABECULAR BONE; VISUAL ANALOG SCALE; ADULT; AGED; BONE REMODELING; BONE TRANSPLANTATION; CONTROLLED CLINICAL TRIAL; DRUG EFFECT; EQUIPMENT; FEMALE; FOLLOW UP; HEALTH STATUS INDICATOR; INTERVERTEBRAL DISK DEGENERATION; INTERVERTEBRAL DISK HERNIA; LUMBAR VERTEBRA; MALE; METHODOLOGY; MIDDLE AGED; PROSPECTIVE STUDY; QUESTIONNAIRE; RADIOGRAPHY; SPINE DISEASE; SPINE FUSION; SPONDYLOLISTHESIS; TREATMENT OUTCOME;

ADULT; AGED; BIOCOMPATIBLE MATERIALS; BONE DENSITY; BONE MORPHOGENETIC PROTEIN 2; BONE REMODELING; BONE TRANSPLANTATION; FEMALE; FOLLOW-UP STUDIES; HEALTH STATUS INDICATORS; HUMANS; INTERVERTEBRAL DISC DEGENERATION; INTERVERTEBRAL DISC DISPLACEMENT; KETONES; LUMBAR VERTEBRAE; MALE; MIDDLE AGED; POLYETHYLENE GLYCOLS; PROSPECTIVE STUDIES; QUESTIONNAIRES; RECOMBINANT PROTEINS; SPINAL DISEASES; SPINAL FUSION; SPONDYLOLISTHESIS; TOMOGRAPHY, X-RAY COMPUTED; TRANSFORMING GROWTH FACTOR BETA; TREATMENT OUTCOME;

MLCS; MLOWN;

EID: 84879755369     PISSN: 00219355     EISSN: 15351386     Source Type: Journal    
DOI: 10.2106/JBJS.L.00137     Document Type: Article

References (36)

1. Sasso RC, LeHuec JC, Shaffrey C; Spine Interbody Research Group. Iliac crest bone graft donor site pain after anterior lumbar interbody fusion: a prospective patient satisfaction outcome assessment. J Spinal Disord Tech. 2005 Feb; 18(Suppl):S77-81
2. Burkus JK, Sandhu HS, Gornet MF, Longley MC. Use of rhBMP-2 in combination with structural cortical allografts: clinical and radiographic outcomes in anterior lumbar spinal surgery. J Bone Joint Surg Am. 2005 Jun;87(6):1205-12
3. Urist MR. Bone: formation by autoinduction. Science. 1965 Nov 12;150(3698):893-9
4. Wozney JM. Overview of bone morphogenetic proteins. Spine (Phila Pa 1976) 2002 Aug 15;27(16)(Suppl 1):S2-8
5. Boden SD, Zdeblick TA, Sandhu HS, Heim SE. The use of rhBMP-2 in interbody fusion cages. Definitive evidence of osteoinduction in humans: a preliminary report Spine (Phila Pa 1976). 2000 Feb 1;25(3):376-81
6. Kleeman TJ, Ahn UM, Talbot-Kleeman A. Laparoscopic anterior lumbar interbody fusion with rhBMP-2: a prospective study of clinical and radiographic outcomes Spine (Phila Pa 1976). 2001 Dec 15;26(24):2751-6
7. Burkus JK, Heim SE, Gornet MF, Zdeblick TA. Is INFUSE bone graft superior to autograft bone? An integrated analysis of clinical trials using the LT-CAGE lumbar tapered fusion device. J Spinal Disord Tech. 2003 Apr;16(2):113-22
8. Boden SD, Kang J, Sandhu H, Heller JG. Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans: a prospective, randomized clinical pilot trial: 2002 Volvo Award in clinical studies Spine (Phila Pa 1976). 2002 Dec 1;27(23):2662-73
9. Dimar J, Glassman SD, Burkus K, Carreon L. Clinical outcomes and fusion success at 2 years of single-level instrumented posterolateral fusions with recombinant human bone morphogenetic protein-2/compression resistant matrix versus iliac crest bone graft. Spine (Phila Pa 1976). 2006 Oct 15;31(22):2534-9, discussion 2540
10. Glassman SD, Carreon L, Djurasovic M, Campbell MJ, Puno RM, Johnson JR, Dimar JR. Posterolateral lumbar spine fusion with INFUSE bone graft. Spine J. 2007 Jan-Feb;7(1):44-9
11. Mummaneni PV, Pan J, Haid RW, Rodts GE. Contribution of recombinant human bone morphogenetic protein-2 to the rapid creation of interbody fusion when used in transforaminal lumbar interbody fusion: a preliminary report. Invited submission from the Joint Section Meeting on Disorders of the Spine and Peripheral Nerves, March 2004. J Neurosurg Spine. 2004 Jul;1(1):19-23
12. Haid RW Jr, Branch CL Jr, Alexander JT, Burkus JK. Posterior lumbar interbody fusion using recombinant human bone morphogenetic protein type 2 with cylindrical interbody cages. Spine J. 2004 Sep-Oct;4(5):527-38, discussion 538-9
13. Hägg O, Fritzell P, Nordwall A; Swedish Lumbar Spine Study Group. The clinical importance of changes in outcome scores after treatment for chronic low back pain Eur Spine J. 2003 Feb;12(1):12-20
14. Patrick DL, Deyo RA, Atlas SJ, Singer DE, Chapin A, Keller RB. Assessing healthrelated quality of life in patients with sciatica. Spine (Phila Pa 1976). 1995 Sep 1;20(17):1899-908, discussion 1909
15. Ware JE, Kosinski M, Bjorner JB, Turner-Bowker DM, Gandek B, Maruish ME User's manual for the SF-36v2. Health Survey. 2nd ed. Lincoln: Quality Metric; 2007
16. Sys J, Weyler J, Van Der Zijden T, Parizel P, Michielsen J. Platelet-rich plasma in mono-segmental posterior lumbar interbody fusion. Eur Spine J. 2011 Oct;20(10):1650-7
17. Kanemura T, Ishikawa Y, Matsumoto A, Sakai Y, Ito Z,Muramoto A, Imagama S Longitudinal radiographic evaluation of maturity of the grafted fusion bone in successful arthrodesis patients after PLIF using interbody carbon cage-A prospective 5-year study. Eur Spine J. 2011;20(Suppl 4):S422
18. Mc Afee PC. Interbody fusion cages in reconstructive operations of the spine J Bone Joint Surg Am. 1999 Jun;81(6):859-80
19. Brantigan JW, Steffee AD, Lewis ML, Quinn LM, Persenaire JM. Lumbar interbody fusion using the Brantigan I/F cage for posterior lumbar interbody fusion and the variable pedicle screw placement system: two-year results from a Food and Drug Administration investigational device exemption clinical trial. Spine (Phila Pa 1976) 2000 Jun 1;25(11):1437-46
20. Villavicencio AT, Burneikiene S, Nelson EL, Bulsara KR, Favors M, Thramann J Safety of transforaminal lumbar interbody fusion and intervertebral recombinant human bone morphogenetic protein-2. J Neurosurg Spine. 2005 Dec;3(6):436-43
21. Mindea SA, Shih P, Song JK. Recombinant human bone morphogenetic protein- 2-induced radiculitis in elective minimally invasive transforaminal lumbar interbody fusions: a series review. Spine (Phila Pa 1976). 2009 Jun 15;34(14):1480-4, discussion 1485
22. Owens K, Glassman SD, Howard JM, Djurasovic M, Witten JL, Carreon LY Perioperative complications with rhBMP-2 in transforaminal lumbar interbody fusion Eur Spine J. 2011 Apr;20(4):612-7
23. Chen Z, Zhao J, Liu A, Yuan J, Li Z. Surgical treatment of recurrent lumbar disc herniation by transforaminal lumbar interbody fusion. Int Orthop. 2009 Feb;33(1):197-201
24. Lauber S, Schulte TL, Liljenqvist U, Halm H, Hackenberg L. Clinical and radiologic 2-4-year results of transforaminal lumbar interbody fusion in degenerative and isthmic spondylolisthesis grades 1 and 2. Spine (Phila Pa 1976). 2006 Jul 1;31(15):1693-8
25. Rihn JA, Patel R, Makda J, Hong J, Anderson DG, Vaccaro AR, Hilibrand AS, Albert TJ. Complications associated with single-level transforaminal lumbar interbody fusion. Spine J. 2009 Aug;9(8):623-9
26. Vaidya R, Sethi A, Bartol S, Jacobson M, Coe C, Craig JG. Complications in the use of rhBMP-2 in PEEK cages for interbody spinal fusions. J Spinal Disord Tech 2008 Dec;21(8):557-62
27. Smoljanovic T, Bojanic I, Delimar D. Adverse effects of posterior lumbar interbody fusion using rhBMP-2. Eur Spine J. 2009 Jun;18(6):920-3, author reply 924
28. Chen NF, Smith ZA, Stiner E, Armin S, Sheikh H, Khoo LT. Symptomatic ectopic bone formation after off-label use of recombinant human bone morphogenetic protein-2 in transforaminal lumbar interbody fusion. J Neurosurg Spine. 2010 Jan;12(1):40-6
29. Wong DA, Kumar A, Jatana S, Ghiselli G, Wong K. Neurologic impairment from ectopic bone in the lumbar canal: a potential complication of off-label PLIF/TLIF use of bone morphogenetic protein-2 (BMP-2). Spine J. 2008 Nov-Dec;8(6):1011-8 Epub 2007 Nov 26
30. Meisel HJ, Schnöring M, Hohaus C, Minkus Y, Beier A, Ganey T, Mansmann U Posterior lumbar interbody fusion using rhBMP-2. Eur Spine J. 2008 Dec;17(12):1735-44
31. Mroz TE, Wang JC, Hashimoto R, Norvell DC. Complications related to osteobiologics use in spine surgery: a systematic review. Spine (Phila Pa 1976). 2010 Apr 20;35(9)(Suppl):S86-104
32. Ahlmann E, PatzakisM, Roidis N, Shepherd L, Holtom P. Comparison of anterior and posterior iliac crest bone grafts in terms of harvest-site morbidity and functional outcomes. J Bone Joint Surg Am. 2002 May;84-A(5):716-20
33. Heary RF, Schlenk RP, Sacchieri TA, Barone D, Brotea C. Persistent iliac crest donor site pain: independent outcome assessment. Neurosurgery. 2002 Mar;50(3):510-6, discussion 516-7
34. Howard JM, Glassman SD, Carreon LY. Posterior iliac crest pain after posterolateral fusion with or without iliac crest graft harvest. Spine J. 2011 Jun;11(6):534-7
35. Carragee EJ, Ghanayem AJ, Weiner BK, Rothman DJ, Bono CM. A challenge to integrity in spine publications: years of living dangerously with the promotion of bone growth factors. Spine J. 2011 Jun;11(6):463-8
36. Gelberman RH, Samson D, Mirza SK, Callaghan JJ, Pellegrini VD Jr. Orthopaedic surgeons and the medical device industry: the threat to scientific integrity and the public trust. J Bone Joint Surg Am. 2010 Mar;92(3):765-77